The #ABTANationalConference2025 is THE place to be this fall to connect with your community.
In-person registration includes access to an intimate reception with @Jas0nTharp, recording artist @ryanneal_music, ABTA-funded research posters to explore, therapy dogs, light apps and more!
Sign up: 🔗 https://t.co/ymGlS1UnM3
Open to all in-person attendees!
#BrainTumorStrong #BrainTumorAwareness #Connect #BrainCancerSupport #BrainTumor #MeetHopeHeadOn #EndBrainTumors #PatientEmpowerment #Support #Community #Strength
@CocoGauff Congratulations Coco. What toughness and fight. Great work in what appeared to be difficult conditions. 2 majors won and many more ahead. Have fun and keep your positive attitude.
Thinking about supporting a CA. #BT5K to help fund vital #braintumor#research and #support services? CA. has 2 events coming up in the Fall. I will be introducing the BT5K Host Committee members for each event throughout May for #BTAM
https://t.co/V9FbX4ys1d @theABTA
A big congratulations to @ucsf neurosurgeon and scientist @herveyjumper on being honored with the Mitchel S. Berger, MD Endowed Professorship! 🎉 @UCSFHospitals@UCSFCancer#UCSFProud
Your donation can plant the seeds of hope! Thanks to a $75K matching challenge, every new or increased gift will be matched dollar-for-dollar. Let’s grow hope together!
Give now & double your impact → https://t.co/G0Ptki1J5P
🚨 Save the Date! The ABTA 2025 National Conference is Sept. 12-14 in Chicago & online!
💡 Learn about cutting-edge treatments 🧠
🧘♀️ Engage in wellness workshops
🤝 Connect with patients, caregivers & experts
🔗 Learn more: https://t.co/0k8LPCqmAo
Our new CEO, Kelly Sitkin, is a 28-year cancer survivor who truly understands the journey of brain tumor patients and their families.
💙 WATCH THE VIDEO: https://t.co/ZTIV34I5y9
#BrainTumorStrong#ABTA#CancerSurvivor#SupportCommunity
🌍 On #WorldCancerDay, we unite with organizations worldwide to advance research, raise awareness, and bring hope to those impacted by cancer. Together, we can end cancer forever. 💙
#EndCancer#HopeAndHealing
#IDH mutations play a critical role in brain tumor diagnosis and treatment by serving as biomarkers for prognosis, aiding in tumor classification, and guiding the use of targeted therapies like IDH inhibitors. Join the ABTA's week-long Ask the Expert with Dr. John de Groot to get your questions about IDH mutations and inhibitors answered Monday, February 3 through Friday, February 7th.
Event Link: https://t.co/KFDVNqt6vI
I am retiring today. I have had the honor and privilege of serving as Pres and CEO of the American Brain Tumor Association for the past 7 years. Thank you @theABTA board, staff, and volunteers. I wish my successor, Kelly Sitkin, and Team ABTA even more success.
Big impact + small commitment. Become a monthly donor and support brain tumor patients. A small monthly donation goes a long way in supporting patients, caregivers, and groundbreaking research.
✨ Join us in doing some serious good: https://t.co/EkFgC0iTYP
IDH inhibitors are reshaping the future of brain tumor care - want to learn more?
Then you won’t want to miss this weeks webinar, "From Mutation to Treatment: Understanding the Impact of IDH Inhibitors."
Discover how IDH inhibitors like the FDA-approved vorasidenib are transforming brain tumor treatment and shaping personalized care. This is a must-attend session for patients, caregivers, and advocates looking to understand the latest advancements in brain tumor therapies.
🔗 Register now: https://t.co/SC6CYRdwzT
#BrainTumorStrong #IDHInhibitors #BTSM
🎗️ Being a caregiver for someone with a brain tumor comes with questions, challenges, and love.
📘 The ABTA Caregiver Handbook offers practical advice, insights, and support to help you navigate this journey.
💌 Order your free copy: https://t.co/a2U0s7IRvr